Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dokl Biol Sci ; 472(1): 1-3, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28429263

RESUMO

Using the audiogenic seizure prone Krushinsky-Molodkina rat strain, it was demonstrated that short-term (5 min) exposure of 14-day-old pups to an elevated temperature (42°C) resulted in a significant decrease in audiogenic seizure severity at the age of 1 month. Presumably, this effect is determined by the activation of the heat-shock protein system (stress proteins).


Assuntos
Epilepsia Reflexa/fisiopatologia , Epilepsia Reflexa/terapia , Resposta ao Choque Térmico , Hipertermia Induzida , Animais , Animais Recém-Nascidos , Ratos
2.
Eksp Klin Farmakol ; 73(7): 2-5, 2010 Jul.
Artigo em Russo | MEDLINE | ID: mdl-20821971

RESUMO

The novel antiepileptic drug levetiracetam (keppra, 80 mg/kg, i.p.) produces a pronounced anticonvulsant effect on all parameters of the audiogenic locomotion response in Wistar rats, leading to the prevention of acoustic seizures approximately in 50% animals. Keppra injection also led to a decrease in the intensity of single audiogenic convulsive episode, a twofold prolongation of the latency of motor reaction, and a change in the pattern of seizure reaction toward increasing number of rats with "one-wave" response. In contrast, a lack of sound resistant animals and the change from one- to two-wave audiogenic response were observed in Krushinsky-Molodkina strain rats.


Assuntos
Anticonvulsivantes/farmacologia , Atividade Motora/efeitos dos fármacos , Piracetam/análogos & derivados , Convulsões/prevenção & controle , Estimulação Acústica , Animais , Anticonvulsivantes/uso terapêutico , Levetiracetam , Masculino , Piracetam/farmacologia , Piracetam/uso terapêutico , Ratos , Ratos Wistar , Tempo de Reação/efeitos dos fármacos , Convulsões/fisiopatologia , Convulsões/psicologia , Especificidade da Espécie
3.
Artigo em Russo | MEDLINE | ID: mdl-19004322

RESUMO

The duration and severity of cataleptic freezing after audiogenic seizures were investigated in rats of several genotypes with different predisposition to audiogenic epilepsy. These genotypes were the Krushinsky-Molodkina strain (KM--the audiogenic seizure prone strain), the Wistar and two new substrains selected from hybrids KM x Wistar for high ("4") and low ("0") audiogenic seizure susceptibility. The drug injections, which modulated the audiogenic fit severity, induced the changes in catalepsy too. It was found, that in intact animals cataleptic freezing developed after audiogenic seizures only and was more intense after severe seizures, the correlation coefficient being statistically significant. Levetiracetam (anticonvulsant drug) injections resulted in significant decrease of audiogenic fit severity and cataleptic state in Wistar and KM rats. Caffeine injections resulted in audiogenic seizures accompanied by cataleptic freezing in rats of the substrain "0", selected for audiogenic non-pronness.


Assuntos
Anticonvulsivantes/uso terapêutico , Catalepsia/fisiopatologia , Epilepsia Reflexa/fisiopatologia , Tono Muscular/fisiologia , Estimulação Acústica , Animais , Benzoatos/uso terapêutico , Cafeína/uso terapêutico , Catalepsia/tratamento farmacológico , Combinação de Medicamentos , Epilepsia Reflexa/tratamento farmacológico , Epilepsia Reflexa/genética , Injeções Intraperitoneais , Levetiracetam , Masculino , Tono Muscular/efeitos dos fármacos , Piracetam/análogos & derivados , Piracetam/uso terapêutico , Ratos , Ratos Wistar , Seleção Genética , Especificidade da Espécie
4.
Artigo em Russo | MEDLINE | ID: mdl-9054163

RESUMO

The anticonvulsant action of diphenin, sodium valproate, and pentobarbital was studied in Krushinskii-Molodkina (KM) rats subjected to audiogenic seizures. The anticonvulsant effects of the drugs were different and dose-dependent. Valproate in a dose of 120 mg/kg completely eliminated the tonic phase of seizures. Given in a dose of 300 mg/kg it in 50% of cases prevented from the development of the initial seizure stage of motor excitation. The peculiarity of the pentobarbital action consisted in its ability to change the character of motor excitation during sound stimulation from the one-wave reaction for the two-wave.


Assuntos
Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Hipnóticos e Sedativos/uso terapêutico , Pentobarbital/uso terapêutico , Fenitoína/uso terapêutico , Convulsões/tratamento farmacológico , Ácido Valproico/uso terapêutico , Estimulação Acústica , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Epilepsia/etiologia , Masculino , Ratos , Ratos Endogâmicos , Convulsões/etiologia
5.
Eksp Klin Farmakol ; 59(6): 6-9, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9181879

RESUMO

The effect of Lamotrigine and carbamazepine on the development and character of the epileptiform seizures after strong sonic stimulation were studied on Krushinskii-Molodkina line of rats. Both drugs manifested a dose-dependent increase in the latency of motor reaction Lamotrigine administration in the dose range of 5-40 mg/kg, i.p., resulted in a moderate decrease in the seizure intensity preventing predominantly the tonic component of the seizure and failed to modify the character of convulsive reaction. Carbamazepine administered in doses of 7.5-30 mg/kg effectively prevented the epileptiform seizures. The "two-wave" motor reaction was observed in 15% of carbamazepine-treated rats.


Assuntos
Anticonvulsivantes/uso terapêutico , Carbamazepina/uso terapêutico , Convulsões/tratamento farmacológico , Triazinas/uso terapêutico , Estimulação Acústica , Animais , Anticonvulsivantes/farmacologia , Carbamazepina/farmacologia , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Lamotrigina , Masculino , Ratos , Ratos Endogâmicos , Tempo de Reação/efeitos dos fármacos , Convulsões/etiologia , Triazinas/farmacologia , Ácido Valproico/farmacologia , Ácido Valproico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA